|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Amortization of right-of-use asset | |||||
| Gain on remeasurement of operating lease liability and right-of-use-asset | |||||
| Impairment of in-process research and development | |||||
| In-process research and development | |||||
| Impairment of right-of-use asset | |||||
| Gain on lease termination | |||||
| Loss on disposal of fixed assets | |||||
| Accrued interest expense | |||||
| Paid-in-kind interest expense | |||||
| Amortization of debt discount and debt issuance costs | |||||
| Forward sales contract expense | |||||
| (Gain) loss on extinguishment of debt | |||||
| Change in fair value of convertible notes | |||||
| Change in fair value of bridge notes derivative liability | |||||
| Fair value adjustments to bridge notes derivative liability | |||||
| Issuance of common stock in connection with settlement | |||||
| Issuance of common stock to consultant for services | |||||
| Change in fair value of warrant liabilities | |||||
| Change in fair value of contingent consideration liability | |||||
| Commitment shares issued to Lincoln Park Capital, LLC | |||||
| Loss on shares sold to Lincoln Park Capital, LLC | |||||
| Non-cash component of acquisition of Exacis in-process research and development | |||||
| Loss on non-controlling investment | |||||
| Changes in operating assets and liabilities: | |||||
| Other receivables | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Accounts payable and accrued expenses | |||||
| Operating lease liability | |||||
| Due from related party | |||||
| Due to related party | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Proceeds received from the sale of fixed assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds received from notes payable | |||||
| Principal payment made on promissory note | |||||
| Gross proceeds | |||||
| Fees paid in connection with private offering | |||||
| Issuance of common stock from exercise of pre-funded warrants | |||||
| Payroll tax remitted on net share settlement of equity awards | |||||
| Fees paid related to the common stock and prefunded warrant offering | |||||
| Proceeds received from exercise of prefunded warrants | |||||
| Proceeds received under promissory note | |||||
| Payment made on promissory note | |||||
| Proceeds from sale of common stock pursuant to stock purchase agreement with Lincoln Park Capital Fund, LLC | |||||
| Dividends paid to Series A preferred stockholders | |||||
| Principal payments on finance leases | |||||
| Fees paid related to the convertible notes financing | |||||
| Proceeds received from bridge notes financing | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash | |||||
| Cash at beginning of period | |||||
| Cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Income taxes | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Repricing of warrants in connection with December 2023 financing | |||||
| Unpaid fees incurred in connection with the December 2023 financing | |||||
| Paid-in-kind interest added to convertible notes principal | |||||
| Initial measurement of lease liabilities | |||||
| Accrual for purchases of property and equipment | |||||
| Conversion of Warrant Liability to Equity | |||||
| Unpaid fees incurred in connection with November 2022 private offering | |||||
| Initial measurement of finance lease liabilities | |||||
| Offset of related party notes payable principal with related party receivable related to issuance of common stock and prefunded warrants | |||||
| Reclassification of forward sales contract to equity upon issuance of common stock | |||||
| Issuance of common stock to Series A preferred stockholders in lieu of cash dividends | |||||
| Adjustment to lease liability and ROU asset due to remeasurement | |||||
| Leasehold improvements funded by tenant improvement allowance | |||||
| Note warrants issued | |||||
| Unpaid fees incurred in connection with the convertible note financing | |||||
| Paid in-kind interest added to convertible notes principal | |||||
| Repricing of warrants in connection with the December 2023 financing | |||||
| Stock issued to Series A preferred stockholders in lieu of cash dividend | |||||
| Initial measurement of ROU assets | |||||
| Initial measurement of lease liability | |||||
| Accrual for purchase of property and equipment | |||||
| Contingent consideration for Exacis asset acquisition | |||||
| Issuance of common stock for Exacis asset acquisition | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Reclassification of warrants to liability | |||||
| Exchange of warrants for common stock | |||||
| Exchange of convertible notes for common stock | |||||
| Conversion of bridge notes for common stock | |||||
| Reclassification of warrants to liabilities | |||||
Loading...